Alanine transaminase levels are accepted as surrogates of NAFLD in clinical practice (30, 31), although liver enzymes are known to be limited in sensitivity and specificity in the diagnosis of pediatric NAFLD (31, 32). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.